Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $25,349 | 9 | 60.5% |
| Unspecified | $5,229 | 10 | 12.5% |
| Travel and Lodging | $4,949 | 20 | 11.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,266 | 7 | 10.2% |
| Food and Beverage | $2,078 | 33 | 5.0% |
| Education | $0.78 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $41,870 | 79 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $750.00 | 2 | GENZYME CORPORATION ($750.00) |
| 2023 | $1,250 | 3 | GENZYME CORPORATION ($1,250) |
| 2022 | $3,576 | 3 | GENZYME CORPORATION ($3,576) |
| 2021 | $4,510 | 2 | GENZYME CORPORATION ($4,510) |
| 2020 | $8,304 | 13 | GENZYME CORPORATION ($8,304) |
| 2019 | $8,958 | 17 | GENZYME CORPORATION ($8,958) |
| 2018 | $11,124 | 27 | GENZYME CORPORATION ($11,124) |
| 2017 | $3,398 | 13 | GENZYME CORPORATION ($3,398) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/07/2024 | GENZYME CORPORATION | LUMIZYME (Biological) | — | In-kind items and services | $500.00 | Research |
| Study: Pompe Disease Registry • Category: Genetic Disease | ||||||
| 01/31/2024 | GENZYME CORPORATION | LUMIZYME (Biological) | — | In-kind items and services | $250.00 | Research |
| Study: Pompe Registry • Category: Genetic Disease | ||||||
| 11/01/2023 | GENZYME CORPORATION | LUMIZYME (Biological) | — | In-kind items and services | $250.00 | Research |
| Study: Pompe Registry • Category: Genetic Disease | ||||||
| 07/03/2023 | GENZYME CORPORATION | NEXVIAZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| Category: Genetic Disease | ||||||
| 02/24/2023 | GENZYME CORPORATION | LUMIZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| Category: Genetic Disease | ||||||
| 09/30/2022 | GENZYME CORPORATION | LUMIZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| Category: Genetic Disease | ||||||
| 09/30/2022 | GENZYME CORPORATION | LUMIZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $250.00 | General |
| Category: Genetic Disease | ||||||
| 09/29/2022 | GENZYME CORPORATION | LUMIZYME (Biological) | Consulting Fee | Cash or cash equivalent | $2,826.00 | General |
| Category: Genetic Disease | ||||||
| 09/28/2021 | GENZYME CORPORATION | LUMIZYME (Biological) | Consulting Fee | Cash or cash equivalent | $1,732.00 | General |
| Category: Genetic Disease | ||||||
| 02/09/2021 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,778.00 | General |
| 06/30/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | — | In-kind items and services | $480.00 | Research |
| Study: Pompe Registry • Category: Genetic Disease | ||||||
| 03/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | — | In-kind items and services | $940.00 | Research |
| Study: Pompe Registry • Category: Genetic Disease | ||||||
| 03/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | — | In-kind items and services | $390.00 | Research |
| Study: Pompe Registry • Category: Genetic Disease | ||||||
| 03/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | — | In-kind items and services | $361.53 | Research |
| Study: Pompe Registry • Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Travel and Lodging | In-kind items and services | $371.28 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Travel and Lodging | In-kind items and services | $270.07 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Food and Beverage | In-kind items and services | $45.15 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Food and Beverage | In-kind items and services | $36.77 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Food and Beverage | Cash or cash equivalent | $22.22 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $20.26 | General |
| Category: Genetic Disease | ||||||
| 01/31/2020 | GENZYME CORPORATION | LUMIZYME (Biological) | Travel and Lodging | Cash or cash equivalent | $17.14 | General |
| Category: Genetic Disease | ||||||
| 09/30/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | — | In-kind items and services | $1,148.57 | Research |
| Study: Pompe Registry • Category: RARE DISEASE GENETICS | ||||||
| 09/30/2019 | GENZYME CORPORATION | LUMIZYME (Drug) | — | In-kind items and services | $454.29 | Research |
| Study: Pompe Registry • Category: RARE DISEASE GENETICS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Pompe Registry | GENZYME CORPORATION | $4,729 | 9 |
| Pompe Disease Registry | GENZYME CORPORATION | $500.00 | 1 |
About Dr. Mary-Alice Abbott, MD
Dr. Mary-Alice Abbott, MD is a Pediatrics healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982799417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary-Alice Abbott, MD has received a total of $41,871 in payments from pharmaceutical and medical device companies, with $750.00 received in 2024. These payments were reported across 80 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($25,349).
Practice Information
- Specialty Pediatrics
- Other Specialties Clinical Genetics (M.D.)
- Location Worcester, MA
- Active Since 10/03/2006
- Last Updated 02/05/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1982799417
Products in Payments
- LUMIZYME (Biological) $15,112
- LUMIZYME (Drug) $10,254
- NO PRODUCT DISCUSSED (Drug) $9,828
- MYOZYME (Drug) $3,398
- NEXVIAZYME (Biological) $500.00
- (820) Cholbam (Drug) $0.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Worcester
Dr. Ann Salerno, M.d, M.D
Pediatrics — Payments: $25,750
Dr. Rumali Medagoda, M.d, M.D
Pediatrics — Payments: $9,419
Dr. Jenifer Lightdale, Md, MD
Pediatrics — Payments: $8,315
Evan Bailey, M.d, M.D
Pediatrics — Payments: $6,456
Sarabeth Broder-Fingert, M.d, M.D
Pediatrics — Payments: $5,500
Dr. Scot Bateman, M.d, M.D
Pediatrics — Payments: $4,400